Treatment of experimental breast cancer with combination of IL-12 gene therapy and anti-VEGFR-2 antibody

被引：0
|
作者：
Rakhmilevich, AL
Hooper, AT
Imboden, M
Hicklin, DJ
Sondel, PM
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] ImClone Syst Inc, New York, NY USA
来源：
CANCER GENE THERAPY | 2003年 / 10卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
102
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [21] A combination of flk1-based DNA vaccine and an immunomodulatory gene (IL-12) in the treatment of murine cancer
    Feng, KK
    Zhao, HY
    Hui, Q
    Liu, JX
    Jian, C
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (05) : 649 - 657
  • [22] Combination therapy of an anti-PDGFRβ antibody with an anti-VEGFR2 antibody leads to enhanced antitumor activity
    Shen, J.
    Prewett, M.
    Damoci, C.
    Zhang, H.
    Vill, M. D.
    Li, H.
    Tonra, J.
    Zhu, Z.
    EJC SUPPLEMENTS, 2008, 6 (12): : 20 - 21
  • [23] The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
    Xie, Xin
    Lv, Jingwen
    Zhu, Wei
    Tian, Chao
    Li, Jingfeng
    Liu, Jiajia
    Zhou, Hua
    Sun, Chunyang
    Hu, Zongfeng
    Li, Xiaopeng
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [24] Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth
    Tamura, T
    Nishi, T
    Goto, T
    Takeshima, H
    Ushio, Y
    Sakata, T
    ANTICANCER RESEARCH, 2003, 23 (2B) : 1173 - 1179
  • [25] Hypoxia-responsive nanogel as IL-12 carrier for anti-cancer therapy
    Zhang, Changhuan
    Li, Qinghua
    Wu, Chenghu
    Wang, Jilong
    Su, Ming
    Deng, Junjie
    NANOTECHNOLOGY, 2021, 32 (09)
  • [26] Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice
    Duechs, M.
    Kratzer, R.
    Lang, I.
    Strobel, B.
    Vieyra-Garcia, P.
    Park, J.
    Kreuz, S.
    Igney, F.
    Klugmann, M.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A86 - A86
  • [27] Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model
    Chuang, Tien-Fu
    Lee, Shan-Chih
    Liao, Kuang-Wen
    Hsiao, Ya-Wen
    Lo, Chia-Hui
    Chiang, Bor-Luen
    Lin, Xi-Zhang
    Tan, Mi-Hua
    Chu, Rea-Min
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) : 698 - 707
  • [28] Anti-tumor mechanism in IL-12 Gene therapy using liposomal bubbles and ultrasound
    Suzuki, Ryo
    Oda, Yusuke
    Koshima, Risa
    Hirata, Keiichi
    Nomura, Tetsuya
    Negishi, Yoichi
    Utoguchi, Naoki
    Nakagawa, Shinsaku
    Maruyama, Kazuo
    10TH INTERNATIONAL SYMPOSIUM ON THERAPEUTIC ULTRASOUND (ISTU 2010), 2011, 1359 : 345 - +
  • [29] Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice
    Duechs, Matthias J.
    Kratzer, Ramona F.
    Vieyra-Garcia, Pablo
    Strobel, Benjamin
    Schoenberger, Tanja
    Gross, Peter
    Aljayyoussi, Ghaith
    Gupta, Aradhana
    Lang, Isabel
    Klein, Holger
    Morilla, Sandra Martinez
    Hopf, Stefan
    Park, John
    Kreuz, Sebastian
    Klugmann, Matthias
    Igney, Frederik H.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [30] IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer
    Wang H.
    Yang G.
    Timme T.L.
    Fujita T.
    Naruishi K.
    Frolov A.
    Brenner M.K.
    Kadmon D.
    Thompson T.C.
    Cancer Gene Therapy, 2007, 14 (10) : 819 - 827
12345